Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04329325
Title Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center

acute lymphoblastic leukemia


Dasatinib + Dexamethasone + Methotrexate

Blinatumomab + Dasatinib + Methotrexate

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST